Preview·CEOInsider is in preview. Some articles shown are illustrative samples created during setup — full, sourced editorial is on the way.

CEOINSIDER
← Leaders

Bernard Pécoul

Drugs for Neglected Diseases Initiative · Switzerland

Bernard Pécoul is the CEO of Drugs for Neglected Diseases Initiative. Pécoul is based in Switzerland. Pécoul was born in 1953 and educated at Tulane University School of Public Health and Tropical Medicine.

Recent developments

AI summary of recent coverage

Recent coverage has focused on Bernard Pécoul's leadership and legacy at the Drugs for Neglected Diseases Initiative, particularly surrounding his departure from the organization after nearly two decades. The headlines document Pécoul's instrumental role in advancing treatments for neglected tropical diseases, including approvals for conditions such as sleeping sickness and malaria, while also highlighting the organization's broader strategy to expand access to medicines for underserved global health priorities.

Summarized from the headlines below; see each source for the full story.

Born
1953
Citizenship
France
Education
Tulane University School of Public Health and Tropical Medicine

Our coverage

On CEOInsider

No feature yet. When we publish a feature, interview or cover story on Bernard Pécoul, it will appear here — and tie into the news timeline.

Bernard Pécoul: FAQ

What company does Bernard Pécoul lead?
Bernard Pécoul is CEO of Drugs for Neglected Diseases Initiative.
Where was Bernard Pécoul educated?
Bernard Pécoul studied at Tulane University School of Public Health and Tropical Medicine.